Design: A longitudinal study was completed with data collected before and at 1, 3, and 6 months after hospital discharge.
A checklist of quality elements was completed with data from 16 projects proposed by 99 teachers from public schools.
This search was completed with data from the Food and Drug Administration, the European Agency for the Evaluation of Medicinal Products and manufacturers.
A quantitative retrospective data analysis will be completed with data ascertained from call centers to determine utilization patterns and uptake of the respective transport systems.
Primary analyses would be completed with data obtained from the intention-to-treat population, while the impact of potential, confounding factors could be investigated within secondary analyses.
Information on drug use is completed with data from community pharmacies, including information on class of antihypertensive medication (ACE inhibitor [ACEi]/angiotensin-2 receptor blocker [ARB]).
Finally, this heterochronous sampling of CHV1 strains was completed with data from two isolates available in Genbank: the complete genomes of the viral strains [EP713] (Shapira et al. 1991) and [Euro7] (Chen and Nuss 1999).
Detailed questionnaires were completed with data about prior contact or any prior TST result; data about HIV infection or other causes of immunosuppression were collected and we looked for the presence of BCG scars.
This step was completed with data from nurses at 8 hospital corporations and sites different from those used in the EFA step (3 community and 5 academic hospitals, including 2 academic paediatric hospitals).
This will be completed with data on dust collection (to dust mite and endotoxin), skin test to most common allergens, stool examinations to helminth and parasites, blood samples (to infection, total and specific IgE, and immunological makers), formaldehyde, physical inspection to diagnoses of eczema, and anthropometric measures.
